Political influences on biotechnology-based innovation for European agriculture: risk-assessment and risk management

ABSTRACT In this paper, we explore how the politics of European regulation and risk governance for innovative agricultural biotechnologies, with the continuing emphasis on the precautionary principle, has problematised conventional norms of evidence-based risk-related decision-making. Based on a study we conducted that analysed how the EU regulatory system had operated in practice in the context of two of the company Syngenta’s genetically modified (GM) crops (Bt11 and GA21), and through two stakeholder workshops, we highlight the tensions in the current regulatory system in Europe, the implications for the future regulation of new and emerging advanced agricultural biotechnologies in the EU, and suggest areas where there may be a need for further regulatory adjustment.

[1]  J. Tait.  SHARE PROJECT #97 ENVIRONMENTAL REGULATION OF ADVANCED INNOVATIVE BIOTECHNOLOGIES: ANTICIPATING FUTURE REGULATORY OVERSIGHT , 2016 .

[2]  David Wield,et al.  The governance of agro- and pharmaceutical biotechnology innovation: Public policy and industrial strategy , 2006, Technol. Anal. Strateg. Manag..

[3]  Joyce Tait,et al.  Upstream engagement and the governance of science , 2009, EMBO reports.

[4]  J. Tait.  From responsible research to responsible innovation: challenges in implementation , 2017 .

[5]  J. S. Legge,et al.  Public Opinion, Risk Assessment, and Biotechnology: Lessons from Attitudes toward Genetically Modified Foods in the European Union , 2010 .

[6]  Karin Edvardsson Björnberg,et al.  Time for a New EU Regulatory Framework for GM Crops? , 2017 .

[7]  Ortwin Renn.  Risk Governance: Coping with Uncertainty in a Complex World , 2008 .

[8]  Ortwin Renn,et al.  Global Risk Governance , 2008 .

[9]  H. Kuiper,et al.  Scientific Opinion on application (EFSA-GMO-UK-2008-60) for placing onthe market of genetically modified herbicide tolerant maize GA21 for foodand feed uses, import, processing and cultivation under Regulation (EC) No1829/2003 from Syngenta Seeds , 2011 .

[10]  A. Raybould,et al.  Protection goals in environmental risk assessment: a practical approach , 2013, Transgenic Research.

[11]  Geoffrey Banda,et al.  Proportionate and adaptive governance of innovative technologies (PAGIT): A framework to guide policy and regulatory decision making , 2017 .

[12]  J. Davison,et al.  New GMO regulations for old: Determining a new future for EU crop biotechnology. , 2017, GM crops & food.

[13]  J. Tait,et al.  Engaging with Uncertainty and Risk in Agricultural Biotechnology Regulation: Delivering Safety and Innovation , 2014 .

[14]  Alan Raybould,et al.  Commercializing genetically modified crops under EU regulations: objectives and barriers. , 2012, GM crops & food.

[15]  Joyce Tait,et al.  More Faust than Frankenstein: the European debate about the precautionary principle and risk regulation for genetically modified crops , 2001 .

[16]  J. Tait.  Environmental Regulation of Advanced Innovative Biotechnologies , 2016 .

[17]  R. Herring.  Opposition to transgenic technologies: ideology, interests and collective action frames , 2008, Nature Reviews Genetics.

[18]  G. Skogstad.  Constructing a Transnational Policy Paradigm in the European Union: the Case of GMO Risk Regulation , 2011 .

[19]  J. Schiemann,et al.  Why the European Union needs a national GMO opt-in mechanism , 2018, Nature Biotechnology.

[20]  Joachim Schiemann,et al.  Guidance document of the scientific panel on genetically modified organisms for the risk assessment of genetically modified plants and derived food and feed: (Question No EFSA-Q-2003-005) , 2004 .

[21]  J. Tosun,et al.  Mobilization in the European Public Sphere: The Struggle Over Genetically Modified Organisms , 2017 .

[22]  Zhuang Fengqing,et al.  Patients’ Responsibilities in Medical Ethics , 2016 .

[23]  G. Wood,et al.  The risk assessment-policy gap: an example from the UK contaminated land regime. , 2006, Environment international.

[24]  Y. Devos,et al.  Towards a more open debate about values in decision-making on agricultural biotechnology , 2014, Transgenic Research.